3 studies found for:    16314626 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting
Has Results
Trial of 2 Cycles of Induction Chemo With Abraxane, Cetuximab, Cisplatin, & 5-FU for Advanced Head and Neck Cancer
Condition: Squamous Cell Carcinoma of the Head and Neck
Interventions: Drug: Abraxane;   Drug: Cetuximab;   Drug: Cisplatin;   Drug: 5-FU;   Radiation: Radiation (Post induction)
2 Completed
Has Results
Study of Cetuximab in Nasopharyngeal Carcinoma (NPC) With Chemoradiotherapy
Condition: Nasopharyngeal Carcinoma
Intervention: Drug: C225 (cetuximab)
3 Completed Cisplatin With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
Condition: Head and Neck Cancer
Interventions: Biological: cetuximab;   Drug: cisplatin

Indicates status has not been verified in more than two years